Point estimation for adaptive trial designs I: A methodological review
Statistics in Medicine · 2023-01-30 · 42 (2) · 122-145
DOI: 10.1002/sim.9605 ↗At a glance
Übersichtsarbeit in Statistics in Medicine, published online on 2022-11-30. Written by David S Robertson and 5 co-authors. Institution: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Major MEDLINE topics: Research Design, Software. Cited 60 times so far (Crossref); 159 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, Department of Health, Cancer Research UK.
Abstract (original language)
Recent FDA guidance on adaptive clinical trial designs defines bias as “a systematic tendency for the estimate of treatment effect to deviate from its true value,” and states that it is desirable to obtain and report estimates of treatment effects that reduce or remove this bias. The conventional end‐of‐trial point estimates of the treatment effects are prone to bias in many adaptive designs, because they do not take into account the potential and realized trial adaptations. While much of the methodological developments on adaptive designs have tended to focus on control of type I error rates and power considerations, in contrast the question of biased estimation has received relatively less attention. This article is the first in a two‐part series that studies the issue of potential bias in point estimation for adaptive trials. Part I provides a comprehensive review of the methods to remove or reduce the potential bias in point estimation of treatment effects for adaptive designs, while part II illustrates how to implement these in practice and proposes a set of guidelines for trial statisticians. The methods reviewed in this article can be broadly classified into unbiased and bias‐reduced estimation, and we also provide a classification of estimators by the type of adaptive design. We compare the proposed methods, highlight available software and code, and discuss potential methodological gaps in the literature.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- MRC Clinical Trials Unit at UCL, London, UK.
- School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
- Centre for Trials Research, Cardiff University, Cardiff, UK.
- Faculty of Informatics and Data Science, University of Regensburg, Regensburg, Germany.
ORCID profiles: David S Robertson, Babak Choodari-Oskooei, Munya Dimairo, Philip Pallmann, Thomas Jaki
Funding
- Medical Research Council
- Department of Health
- Cancer Research UK
- Health and Care Research Wales
- Medical Research Council Canada
- National Institute for Health Research
Cite
APA
Robertson, D. S., Choodari-Oskooei, B., Dimairo, M., Flight, L., Pallmann, P., & Jaki, T. (2023). Point estimation for adaptive trial designs I: A methodological review. Statistics in Medicine, 42(2), 122-145. https://doi.org/10.1002/sim.9605
Vancouver
Robertson DS, Choodari-Oskooei B, Dimairo M, Flight L, Pallmann P, Jaki T. Point estimation for adaptive trial designs I: A methodological review. Statistics in Medicine. 2023;42(2):122-145. doi:10.1002/sim.9605
BibTeX
@article{Robertson2023,
author = {Robertson, David S and Choodari-Oskooei, Babak and Dimairo, Munya and Flight, Laura and Pallmann, Philip and Jaki, Thomas},
title = {Point estimation for adaptive trial designs I: A methodological review},
journal = {Statistics in Medicine},
year = {2023},
volume = {42},
number = {2},
pages = {122--145},
doi = {10.1002/sim.9605}
}
EUVIMED